Vaccination is recommended for vulnerable people such as the very young and the old.
Keystone
Flu season has hit Switzerland, with babies and children under five the most affected, according to latest figures from the Federal Office of Public Health (FOPH).
In the second week of January, 144 doctors in the Sentinella tracking project recorded an average 15.5 out of 1,000 medical consultations for influenza. This translates to 121 cases per 100,000 people in the past week, meaning the epidemic threshold of 68 per 100,000 has been crossed, says the FOPHExternal link.
An epidemic level has been declared for all age categories, except for the over 65s, where the rate is 64 cases per 100,000 people.
The infectious illness is particularly virulent in the cantons of Graubünden and Ticino, according to the FOPH, and least severe in the cantons of Jura, Bern and Fribourg.
Epidemics are recorded each winter in Switzerland, says the FOPHExternal link (link in French). Their length, the types of flu strain and their effects on the population can vary from year to year. Vaccination is recommended for those most at risk, especially babies, over-65s, pregnant women and those suffering from chronic illnesses.
Popular Stories
More
Culture
Wealth is not all: how gentrification in Zurich has led to housing shortage
Is reforming the Swiss pension system still possible, and if so, how?
Solutions still need to be found to meet the challenge of an ageing population and to improve the pensions of low-paid workers, the majority of whom are women.
Job prospects remain good in Switzerland – apart from in Ticino
This content was published on
Employment prospects remain positive in Switzerland as a whole, but they are negative in southern Italian-speaking canton Ticino.
This content was published on
In an international comparison, Swiss adults perform above average in the basic skills of reading, everyday math and problem solving.
New carrier particle discovered for transporting drugs in body
This content was published on
Researchers at the federal technology institute ETH Zurich have discovered particles that can be used to deliver drugs precisely, for example to a cancerous tumour in the body.
Swiss parliament clears way for new start with e-ID
This content was published on
A new attempt to introduce electronic proof of identity has been made in Switzerland. The Senate has resolved the final differences in the legal provisions on a state e-ID.
Sixteen-day Swiss campaign against gender-based violence ends
This content was published on
The 16-day campaign against gender-based violence came to an end on Tuesday. Several hundred organizations mobilized across Switzerland during this period.
Swiss parliament wants CHF15 million for women’s Euro 2025
This content was published on
Parliament wants Switzerland to support next year's European Women's Football Championship with CHF15 million ($17 million).
Rare Roman coin auctioned for almost CHF2 million in Geneva
This content was published on
A rare Roman coin with a portrait of Brutus, the assassin of Julius Caesar, was sold at a Geneva auction on Monday for CHF1.89 million ($2.15 million), according to the organiser of the sale.
Swiss Senate approves federal budget without opposition
This content was published on
The Swiss army will receive an additional CHF530 million in 2025, and no cuts will be made to direct payments for agriculture. What is unclear is how much will be saved on foreign aid.
Swiss suspend decisions on asylum-seekers from Syria
This content was published on
Asylum procedures and decisions for asylum-seekers from Syria will be suspended with immediate effect until the situation can be reassessed, the State Secretariat for Migration (SEM) said.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Cancer expected to kill 18,000 Swiss this year
This content was published on
More than 56,000 new cases of cancer will be diagnosed in Switzerland in 2018, says a report released by the World Health Organization (WHO).
This content was published on
There are far more people with dementia in Switzerland than previously thought – and the number is expected to double over the next 25 years.
This content was published on
Switzerland could save millions of francs by prescribing low-priced biotech drug copies, known as biosimilars, instead of expensive biologicals.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.